147 related articles for article (PubMed ID: 25609053)
1. Peripheral blood leukocyte expression level of lncRNA steroid receptor RNA activator (SRA) and its association with polycystic ovary syndrome: a case control study.
Liu Z; Hao C; Huang X; Zhang N; Bao H; Qu Q
Gynecol Endocrinol; 2015 May; 31(5):363-8. PubMed ID: 25609053
[TBL] [Abstract][Full Text] [Related]
2. Silencing of LncRNA steroid receptor RNA activator attenuates polycystic ovary syndrome in mice.
Li Y; Zhao W; Wang H; Chen C; Zhou D; Li S; Zhang X; Zhao H; Zhou D; Chen B
Biochimie; 2019 Feb; 157():48-56. PubMed ID: 30391287
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA H19 is associated with polycystic ovary syndrome in Chinese women: a preliminary study.
Qin L; Huang CC; Yan XM; Wang Y; Li ZY; Wei XC
Endocr J; 2019 Jul; 66(7):587-595. PubMed ID: 30982795
[TBL] [Abstract][Full Text] [Related]
4. Up-Regulation of Long Noncoding RNA SRA Promotes Cell Growth, Inhibits Cell Apoptosis, and Induces Secretion of Estradiol and Progesterone in Ovarian Granular Cells of Mice.
Li Y; Wang H; Zhou D; Shuang T; Zhao H; Chen B
Med Sci Monit; 2018 Apr; 24():2384-2390. PubMed ID: 29674607
[TBL] [Abstract][Full Text] [Related]
5. Association between long-chain non-coding RNA SRA1 gene single-nucleotide polymorphism and polycystic ovary syndrome susceptibility.
Tan J; Hao X; Zhao T; Ying J; Li T; Cheng L
J Assist Reprod Genet; 2020 Oct; 37(10):2513-2523. PubMed ID: 32783135
[TBL] [Abstract][Full Text] [Related]
6. Elevated Circulating Levels of Carnal ENST00000550337.1 Are Associated with Polycystic Ovary Syndrome in Chinese Women.
Qi Y; Yin Q; Gu J; Liu Y; Sun Q; Cao Y; Yan X; Yuan Y; Wu J
Gynecol Obstet Invest; 2021; 86(1-2):155-161. PubMed ID: 33601399
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing.
Fu LL; Xu Y; Li DD; Dai XW; Xu X; Zhang JS; Ming H; Zhang XY; Zhang GQ; Ma YL; Zheng LW
Gene; 2018 May; 657():19-29. PubMed ID: 29505837
[TBL] [Abstract][Full Text] [Related]
8. Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism.
Jin L; Yang Q; Zhou C; Liu L; Wang H; Hou M; Wu Y; Shi F; Sheng J; Huang H
Reprod Biomed Online; 2018 Nov; 37(5):613-623. PubMed ID: 30224242
[TBL] [Abstract][Full Text] [Related]
9. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.
Murri M; Insenser M; Fernández-Durán E; San-Millán JL; Luque-Ramírez M; Escobar-Morreale HF
Metabolism; 2018 Sep; 86():49-60. PubMed ID: 29410349
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNAs: Potential Regulators Involved in the Pathogenesis of Polycystic Ovary Syndrome.
Liu YD; Li Y; Feng SX; Ye DS; Chen X; Zhou XY; Chen SL
Endocrinology; 2017 Nov; 158(11):3890-3899. PubMed ID: 28938484
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor coregulator long noncoding RNA CTBP1-AS is associated with polycystic ovary syndrome in Kashmiri women.
Nabi M; Andrabi SM; Rasool SUA; Ashraf S; Majid I; Amin S
Endocrine; 2022 Feb; 75(2):614-622. PubMed ID: 34611799
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptor RNA activator: Biologic function and role in disease.
Liu C; Wu HT; Zhu N; Shi YN; Liu Z; Ao BX; Liao DF; Zheng XL; Qin L
Clin Chim Acta; 2016 Aug; 459():137-146. PubMed ID: 27282881
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.
Sang Q; Zhang S; Zou S; Wang H; Feng R; Li Q; Jin L; He L; Xing Q; Wang L
Reprod Biomed Online; 2013 Feb; 26(2):157-63. PubMed ID: 23265961
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the lncRNA SRLR in polycystic ovary syndrome regulates cell apoptosis and IL-6 expression.
Li L; Zhu J; Ye F; Duan Z; Zhou J; Huang Z; Wang L
Cell Biochem Funct; 2020 Oct; 38(7):880-885. PubMed ID: 31999854
[TBL] [Abstract][Full Text] [Related]
15. Expression of serum lncRNA-Xist in patients with polycystic ovary syndrome and its relationship with pregnancy outcome.
Liu M; Zhu H; Li Y; Zhuang J; Cao T; Wang Y
Taiwan J Obstet Gynecol; 2020 May; 59(3):372-376. PubMed ID: 32416882
[TBL] [Abstract][Full Text] [Related]
16. Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression.
Murri M; Insenser M; Fernández-Durán E; San-Millán JL; Escobar-Morreale HF
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1835-44. PubMed ID: 24037889
[TBL] [Abstract][Full Text] [Related]
17. Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome.
Kim JW; Kang KM; Yoon TK; Shim SH; Lee WS
Fertil Steril; 2014 Aug; 102(2):548-554.e2. PubMed ID: 24875397
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].
Yang Y; Qiao J; Li MZ
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):9-13. PubMed ID: 22455686
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNAs as a piece of polycystic ovary syndrome puzzle.
Abolghasemi M; Mahjoub S
Mol Biol Rep; 2021 Apr; 48(4):3845-3851. PubMed ID: 33993404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
